People | February 28, 2026
Lupin’s Vinita Gupta honoured as CNBC Changemaker for revolutionising U.S. healthcare access
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
KEYTRUDA had previously met its primary endpoint of progression-free survival in all patients
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
The company said the move applies to all doses and reflects its commitment to making its medicines more affordable for patients
The innovative eyedrop targets inflammation and pain following ocular surgery
CagriSema produced a 23% weight loss at 84 weeks, versus 25.5% for tirzepatide
Brivaracetam is the bioequivalent to Briviact Oral Solution, 10 mg/mL, of UCB
To support this launch, ImmunityBio has established a wholly owned subsidiary in Saudi Arabia
The results mark a potential breakthrough for patients living with CIndU, a condition with limited treatment options
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
Subscribe To Our Newsletter & Stay Updated
